Bank of Maharashtra Leads PSU Pack on CASA Strength; Gland Pharma Weighed by US Pricing

BoM's stable deposit base and asset-quality gains offer defensive appeal; Gland's injectable franchise is solid but Fosun overhang and US generics pressure cap upside. Honasa restructuring adds near-term risk.

ndtv-profit-business · 6/30/2026, 3:17:43 AM · Ask about this →